2023
DOI: 10.3389/fendo.2023.1224381
|View full text |Cite
|
Sign up to set email alerts
|

ACTH-producing small cell neuroendocrine carcinoma from the gallbladder: a case report and literature review

Xiaofang Zhang,
Dihua Huang,
Xiaojie Pan
et al.

Abstract: Ectopic adrenocorticotropic hormone syndrome (EAS) is a condition of hypercortisolism caused by non-pituitary tumors that secrete adrenocorticotropic hormone (ACTH). A rare occurrence of this syndrome is due to an ACTH-producing neuroendocrine tumor that originates from the gallbladder. One patient with severe hypokalemia and alkalosis was admitted to our hospital. Clinical presentations and radiographic findings confirmed the diagnosis of an aggressive ACTH-producing gallbladder malignancy with multiple liver… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Functional tumors, due to their ability to produce hormones like serotonin, CgA, adrenocorticotropic hormone (ACTH), and gastrin, may exhibit hormone-related side effects, such as flushing, diarrhea, and coughing. [ 15 , 21 , 22 ] Most cases of gallbladder cancer do not exhibit typical clinical signs or symptoms in the early stages, and as such, they are often found at an advanced stage. Consequently, fewer than 20% of patients are eligible for a complete surgical resection.…”
Section: Discussionmentioning
confidence: 99%
“…Functional tumors, due to their ability to produce hormones like serotonin, CgA, adrenocorticotropic hormone (ACTH), and gastrin, may exhibit hormone-related side effects, such as flushing, diarrhea, and coughing. [ 15 , 21 , 22 ] Most cases of gallbladder cancer do not exhibit typical clinical signs or symptoms in the early stages, and as such, they are often found at an advanced stage. Consequently, fewer than 20% of patients are eligible for a complete surgical resection.…”
Section: Discussionmentioning
confidence: 99%